Lynch & Associates’s Cigna CI Stock Holding History

Lynch & Associates’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.1M	Sell	4,035 -3	-0.1%	-$845	0.16%	86
2026 Q2	$1.11M	Buy	4,038 +387	+11%	+$109K	0.19%	84
2026 Q1	$974K	Buy	3,651 +610	+20%	+$169K	0.18%	85
2025 Q4	$837K	Sell	3,041 -784	-20%	-$220K	0.16%	86
2025 Q3	$1.1M	Sell	3,825 -548	-13%	-$162K	0.21%	79
2025 Q2	$1.45M	Sell	4,373 -2	-0%	-$645	0.29%	71
2025 Q1	$1.44M	Buy	4,375 +30	+0.7%	+$9.04K	0.31%	68
2024 Q4	$1.2M	Sell	4,345 -159	-4%	-$50.7K	0.26%	71
2024 Q3	$1.56M	Buy	4,504 +154	+4%	+$53K	0.33%	66
2024 Q2	$1.44M	Buy	4,350 +585	+16%	+$202K	0.32%	66
2024 Q1	$1.37M	Buy	3,765 +412	+12%	+$136K	0.32%	66
2023 Q4	$1M	Buy	3,353 +1,263	+60%	+$369K	0.24%	71
2023 Q3	$598K	Buy	+2,090	New	+$596K	0.16%	78

Other funds holding CI

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Ranmore Fund Management Cobham, United Kingdom $901M AUM 11.24% 1-Year Est. Return

Wilsey Asset Management San Diego, California $681M AUM 1.1% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Davidson Investment Advisors Great Falls, Montana $2.39B AUM 16.28% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

J.L. Bainbridge & Co Sarasota, Florida $1.32B AUM 22.53% 1-Year Est. Return

Lynch & Associates's CI Position: Q3 2026 in Review

Lynch & Associates reduced its Cigna (CI) stake by 0.07% in Q3 2026, selling an estimated $845 and leaving 4,035 shares worth $1.1M. The position accounts for 0.16% of the portfolio, ranked #86.

Lynch & Associates first reported a position in CI in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.56M in Q3 2024. 323 funds tracked by Wall St. Rank hold CI as of Q3 2026.

Lynch & Associates held 4,035 shares of Cigna worth $1.1M as of Q3 2026.
Lynch & Associates sold 3 Cigna shares in Q3 2026, an estimated $845.
Cigna made up 0.16% of Lynch & Associates's portfolio in Q3 2026, its #86 holding.
Lynch & Associates first reported a position in Cigna in Q3 2023 and has held it in 13 quarters since.
Lynch & Associates's Cigna position peaked at $1.56M in Q3 2024.
323 funds tracked by Wall St. Rank held Cigna as of Q3 2026.

Based on Lynch & Associates's 13F filing for Q3 2026, filed 13 Oct 2026.